Literature DB >> 2541929

Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP.

S M Taffet1, K J Singhel, J F Overholtzer, S A Shurtleff.   

Abstract

Bacterial lipopolysaccharide (LPS, 1 microgram/ml) induced the rapid production of tumor necrosis factor (TNF-alpha) mRNA in the RAW264 macrophage-like cell line. TNF-alpha mRNA peaked within 45 min of LPS treatment and remained high for greater than 3 hr. Transcription of TNF-alpha mRNA was increased within 15 min of LPS treatment. The quantity of TNF-alpha mRNA in LPS-stimulated cells was reduced to basal levels by treatment with cAMP, cAMP analogs, or agents which raise intracellular cAMP. This was not a general effect on all mRNA levels as the expression of a second gene, ornithine decarboxylase, was enhanced by cAMP treatment. cAMP did not have an effect on the stability of TNF-alpha mRNA. This is in contrast to the protein synthesis inhibitor, cycloheximide, which leads to a stabilization of TNF-alpha mRNA. Our results suggest that the primary regulation of tumor necrosis factor by cAMP and LPS occurs at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541929     DOI: 10.1016/0008-8749(89)90198-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

1.  Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation.

Authors:  Christian Brenneis; Ovidiu Coste; Kai Altenrath; Carlo Angioni; Helmut Schmidt; Claus-Dieter Schuh; Dong Dong Zhang; Marina Henke; Andreas Weigert; Bernhard Brüne; Barry Rubin; Rolf Nusing; Klaus Scholich; Gerd Geisslinger
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

2.  A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment.

Authors:  F Myokai; S Takashiba; R Lebo; S Amar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 3.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Chromatin structure and DNase I hypersensitivity in the transcriptionally active and inactive porcine tumor necrosis factor gene locus.

Authors:  P Kuhnert; E Peterhans; U Pauli
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

5.  Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages.

Authors:  Joseph Brown; Mark A Wallet; Bryan Krastins; David Sarracino; Maureen M Goodenow
Journal:  J Leukoc Biol       Date:  2010-04       Impact factor: 4.962

6.  Transforming growth factor-beta in a model of IgA switching.

Authors:  D Y Kunimoto
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  Role of Kupffer cells in developing streptococcal cell wall granulomas. Streptococcal cell wall induction of inflammatory cytokines and mediators.

Authors:  C L Manthey; T Kossmann; J B Allen; M L Corcoran; M E Brandes; S M Wahl
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

8.  Influence of unsaturated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages.

Authors:  P S Tappia; W J Man; R F Grimble
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

9.  Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms.

Authors:  S Kassis; U Prabhakar; J C Lee
Journal:  Agents Actions       Date:  1993

10.  Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.

Authors:  L Schandené; P Vandenbussche; A Crusiaux; M L Alègre; D Abramowicz; E Dupont; J Content; M Goldman
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.